Phleum pratense pollen
- Generic Name
- Phleum pratense pollen
- Brand Names
- Grastek, Oralair 100, Oralair 300, Oralair Children and Adolescents Sample Kit
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 0P46LFE4VC
- Background
Phleum pratense pollen allergenic extract is used in allergenic testing.
- Indication
Phleum pratense pollen is an allergen extract included in an allergenic testing product called ORALAIR. It is indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen38 specific IgE antibodies for any of the five grass species contained in this product. ORALAIR is approved for use in persons 5 through 65 years of age.
- Associated Conditions
- Allergic Rhinitis Due to Pollen
- Associated Therapies
- -
miRNA-155 Assay Before and After Immunotherapy and Probiotics
- Conditions
- Interventions
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2020-10-29
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 45
- Registration Number
- NCT04603456
- Locations
- 🇪🇬
Zagazig university, Zagazig, Sharkia, Egypt
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
- Conditions
- Interventions
- First Posted Date
- 2007-12-04
- Last Posted Date
- 2010-05-05
- Lead Sponsor
- Artu Biologicals
- Target Recruit Count
- 605
- Registration Number
- NCT00567346
- Locations
- 🇧🇬
MHAT PLovdiv, ENT Clinic, Plovdiv, Bulgaria
🇧🇬MHAT Sveta Marina, Varna, Bulgaria
🇨🇿ORL Soukroma praxe, Brno, Czech Republic
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.